Overview

Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section. The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Ropivacaine
Criteria
Inclusion Criteria:

- eligible for elective caesarean section

- able to speak and understand Danish

- able to give informed consent

Exclusion Criteria:

- alcohol or medical abuse

- allergies to local anesthetics

- age < 18 years

- intolerance to opioids